Table 2 Logistic regressions showing the association between growth hormone (GH) and bipolar disorder.

From: Cerebrospinal fluid proteomic study of two bipolar disorder cohorts

SBP-S (n = 209)

β

SE

OR

95% CI

p

GH

−0.47

0.22

0.63

0.40–0.96

0.035

Age

−0.01

0.01

0.99

0.97–1.01

0.455

Male sex

−0.89

0.35

0.41

0.20–0.80

0.011

BMI

0.039

0.051

1.04

0.94–1.15

0.443

Nicotine use

0.99

0.32

2.69

1.44–5.16

0.002

Albumin ratio

0.17

0.078

1.18

1.02–1.38

0.034

SBP-G (n = 122)

β

SE

OR

95% CI

p

GH

−0.69

0.32

0.50

0.26–0.93

0.033

Age

−0.05

0.02

0.95

0.91–0.98

0.006

Male sex

−1.20

0.49

0.30

0.11–0.77

0.015

BMI

0.013

0.065

1.01

0.89–1.15

0.840

Nicotine use

0.96

0.44

2.60

1.13–6.30

0.028

Albumin ratio

0.10

0.12

1.10

0.87-1.41

0.424

  1. Case–control status is dependent variable. Age, sex, BMI, CSF/serum albumin ratio and nicotine use are covariates.
  2. p-values smaller than 0.05 are shown in bold.
  3. BMI body mass index, CI confidence interval, CSF cerebrospinal fluid, OR odds ratio, SE standard error, SBP-G St. Göran bipolar project Gothenburg, SBP-S St. Göran bipolar project Stockholm.
Back to article page